Clinical Trial Update: MRD in PAAD Adjuvant Therapy [NA]

View source ↗

Summary

This clinical trial update indicates an ongoing study at Peking Union Medical College Hospital evaluating the role of molecular residual disease in guiding adju…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: The Role of Molecular Residual Disease in the Treatment Strategy and Prognosis Prediction of Pancreatic Cancer Patients Undergoing Adjuvant Therapy, Molecular Residual Disease | NA | Status: ACTIVE_NOT_RECRUITING